Dr Sedona Sweeney
in Health Economics
15-17 Tavistock Place
020 7927 2890
Sedona is a health economist, with a research focus on economic evaluation in low- and middle-income settings. Her particular interest is in the economic impact of substantial long-term health shocks, both at the provider level and within the household. Her research to date has been focused on measurement and understanding of the costs of chronic illness – including HIV, TB, chronic non-communicable diseases, and HCV
Department of Global Health and Development
Faculty of Public Health and Policy
Centre for Evaluation
Sedona is the Deputy Module Organizer for the Distance Learning module on the Economics of Global Health Policy. She also supervises in-person MSc students on the Health Policy, Planning, and Financing course.
Sedona's current research projects include:
- TB PRACTECAL: a phase II/III clinical research project to find short, tolerable and effective treatments for people with drug-resistant tuberculosis (DR-TB)
- XACT-III: a pragmatic, multi-country, open-labelled, randomised controlled trial to evaluate a scalable active case finding intervention for TB using a point-of-care molecular tool
- FEND-TB: a global research consortium supporting the evaluation of early-stage TB diagnostics & novel diagnostic strategies in the context of existing clinical algorithms in TB endemic countries
- iHOST: an intervention that aims to improve hospital care for people who use opioids by removing barriers to opioid withdrawal management.
- TB MAC: the TB Modelling and Analysis Consortium
- VALUE-TB: a collaboration between LSHTM, University of Cape Town, and WHO aiming to collect cost data to facilitate decision-making for TB in five countries (incl. Kenya, Ethiopia, Philippines, India, and Georgia)
- the Global Health Cost Consortium: which aims to mitigate the TB and HIV epidemics by systematically improving the availability, quality, timing, relevance, interpretation, and use of cost information on HIV and tuberculosis (TB) programs and services
- the Integra Initiative: an analysis of integrated HIV and sexual and reproductive health services in Kenya and Swaziland
- the Health Systems Chronic Disease project: a project aiming to improve the health systems response to chronic disease in Uganda and Tanzania
- a project assessing the impact and cost-effectiveness of needle/syringe provision on hepatitis C transmission among people who inject drugs in the UK
- the MERGE project: evaluating a model of scaling-up integrated TB and HIV services in South Africa
Social and structural determinants of health
Randomised controlled trials
Disease and Health Conditions
Sexually transmitted disease
East Asia & Pacific (developing only)
Europe & Central Asia (all income levels)
Least developed countries: UN classification
Sub-Saharan Africa (developing only)
Digital adherence technologies to improve tuberculosis treatment outcomes: a cluster-randomised superiority trial
Cold Spring Harbor Laboratory
Efficiency of TB service provision in the public and private health sectors in Ethiopia.
International Journal of Tuberculosis and Lung Disease
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis
PLOS Global Public Health
TB-PRACTECAL: the economic case for 24-week BPaL-based treatments for drug-resistant TB
Cost of TB services: approach and summary findings of a multi-country study (Value TB).
International journal of tuberculosis and lung disease
More treatment options for rifampicin-resistant tuberculosis: the role of economic evaluation in informing uptake.
The Lancet Global Health
Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countries.
Wellcome open research